[ Price : $8.95]
FDA issues Teva Pharmaceuticals and MedinCell a complete response letter on their NDA for TV-46000/mdc-IRM (risperidone extended-r...[ Price : $8.95]
Federal Register notice: FDA announces a 5/18-19 meeting of the Science Advisory Board to the National Center for Toxicological Re...[ Price : $8.95]
FDA warns the Norcross, GA-based Center for Rare Neurological Diseases about human subject protection violations in its conduct of...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance for industry #106 entitled The Use of Published Literature in Suppor...[ Price : $8.95]
Federal Register notice: FDA corrects a 2/28 notice announcing the withdrawal of approval of five ANDAs from multiple applicants.[ Price : $8.95]
FDA warns St. Louis, MO-based Vi-Jon about CGMP violations in its production of finished drugs.[ Price : $8.95]
Based on adverse events received, FDA sends Warning Letters to 12 companies for selling unapproved over-the-counter products inten...[ Price : $8.95]
Two Arnall Golden Gregory attorneys recommend that drug companies keep all FDA promotion regulations in mind when they craft consu...